Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research



Randomized clinical trials related to urticaria: Bibliometric analysis from 2009 to 2019

Anant D Patil.

Abstract
Background: Urticaria is associated with considerable health-care costs. Randomized controlled trials (RCTs) are considered as the gold standard for evaluating efficacy in clinical research.

Aims and Objectives: The objective of this study was to analyze RCTs in the therapeutic area of urticaria from 2009 to 2019.

Materials and Methods: Systematic search of “PubMed” was performed using words “Study[ti] OR trial[ti] AND urticaria[ti] AND “2009” [Date – Publication]: “2019” [Date – Publication].” All retrieving articles were screened for understanding the study design. RCTs were considered for further analysis. Year-wise and indication-wise analysis of RCTs was performed.

Results: Of 189 articles retrieved, nine articles did not satisfy the inclusion criteria. Of 180 articles, 6 (3.3%) articles were published in 2009. In subsequent years (2010–2019), the number (%) of articles published was 8 (4.4%), 9 (5%), 10 (5.6%), 12 (6.7%), 14 (7.8%) 15 (8.3%), 15 (8.3%), 20 (11.1%), 32 (17.8%), and 39 (21.7%), respectively. A total of 47 (26.11%) were RCTs. The number (%) of RCTs from 2009 to 2019 was 2 (4.26%), 3 (6.38%), 2 (4.26%), 3 (6.38%), 4 (8.51%), 5 (10.64%), 3 (6.38%), 4 (8.51%), 6 (12.77%), 7 (14.89%), and 8 (17.01%), respectively. A total of 31 (65.96%) RCTs were related to chronic spontaneous urticaria/chronic idiopathic urticaria (CSU/CIU).

Conclusion: Analysis of articles showed that the numbers of RCTs related to urticaria are increasing over the years. CSU/CIU is the most commonly researched topic in urticaria through RCTs.

Key words: Randomized Controlled Trials; Urticaria; Research



Similar Articles

Biovalue in Human Brain Banking: Applications and Challenges for Research in Neurodegenerative Diseases.
Vedam-Mai V
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 209-220

Advancing Our Understanding of Brain Disorders: Research Using Postmortem Brain Tissue.
Curtis MA, Vedam-Mai V
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 201-208

Research advances on how metformin improves memory impairment in "chemobrain".
Alhowail A, Chigurupati S
Neural regeneration research. 2022; 17(1): 15-19

The unintended consequences of the pandemic on non-pandemic research activities.
Walker J, Brewster C, Fontinha R, Haak-Saheem W, Benigni S, Lamperti F, Ribaudo D
Research policy. 2022; 51(1): 104369

NASA's Ground-Based Microgravity Simulation Facility.
Zhang Y, Richards JT, Hellein JL, Johnson CM, Woodall J, Sorenson T, Neelam S, Ruby AMJ, Levine HG
Methods in molecular biology (Clifton, N.J.). 2022; 2368(): 281-299


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites